The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Slagel Dean since year 2005.
The trader's CIK number is 1597359.
At the time of this reporting, Slagel Dean is the Director of Cara Therapeutics, Inc. .
(stock ticker symbol CARA).
See this page for all insider trading activities at Cara Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-06-29||CARA||Cara Therapeutics, Inc.||Sale||250,000||26.20||6,548,750|
|2015-12-31||CARA||Cara Therapeutics, Inc.||Sale||12,776||17.00||217,192|
|2016-01-05||CARA||Cara Therapeutics, Inc.||Sale||31,224||17.01||531,120|
|2015-05-15||CARA||Cara Therapeutics, Inc.||Sale||73,600||10.00||736,000|
|2015-05-19||CARA||Cara Therapeutics, Inc.||Sale||32,266||10.00||322,660|
|2015-05-18||CARA||Cara Therapeutics, Inc.||Sale||82,945||10.04||832,767|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Slagel Dean (Director of Cara Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.